Tags

Type your tag names separated by a space and hit enter

Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program.
MMWR Morb Mortal Wkly Rep. 2003 Feb 07; 52(5):88-9, 99.MM

Abstract

Smallpox vaccination of civilian volunteer health-care workers began on January 24, 2003. As of February 4, a total of 37 states and counties have received shipments of smallpox vaccine, and 18 states and counties have begun smallpox vaccination; no serious adverse events have been reported. To monitor the occurrence of adverse events associated with vaccination, both those expected on the basis of previous experience and possible new unexpected adverse events, CDC and state health departments have established the Smallpox Vaccine Adverse Events Monitoring and Response System. The system also will be used to monitor the effectiveness of contraindication screening, identify new contraindications, and coordinate the distribution of vaccinia immune globulin (VIG) and cidofovir to the civilian population. This notice describes the components of the system, delineates roles and responsibilities, and explains how data from the system will be compiled and communicated.

Authors

Pub Type(s)

Journal Article

Language

eng

PubMed ID

12588007

Citation

Centers for Disease Control and Prevention (CDC). "Smallpox Vaccine Adverse Events Monitoring and Response System for the First Stage of the Smallpox Vaccination Program." MMWR. Morbidity and Mortality Weekly Report, vol. 52, no. 5, 2003, pp. 88-9, 99.
Centers for Disease Control and Prevention (CDC). Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program. MMWR Morb Mortal Wkly Rep. 2003;52(5):88-9, 99.
Centers for Disease Control and Prevention (CDC). (2003). Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program. MMWR. Morbidity and Mortality Weekly Report, 52(5), 88-9, 99.
Centers for Disease Control and Prevention (CDC). Smallpox Vaccine Adverse Events Monitoring and Response System for the First Stage of the Smallpox Vaccination Program. MMWR Morb Mortal Wkly Rep. 2003 Feb 7;52(5):88-9, 99. PubMed PMID: 12588007.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program. A1 - ,, PY - 2003/2/18/pubmed PY - 2003/2/26/medline PY - 2003/2/18/entrez SP - 88-9, 99 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 52 IS - 5 N2 - Smallpox vaccination of civilian volunteer health-care workers began on January 24, 2003. As of February 4, a total of 37 states and counties have received shipments of smallpox vaccine, and 18 states and counties have begun smallpox vaccination; no serious adverse events have been reported. To monitor the occurrence of adverse events associated with vaccination, both those expected on the basis of previous experience and possible new unexpected adverse events, CDC and state health departments have established the Smallpox Vaccine Adverse Events Monitoring and Response System. The system also will be used to monitor the effectiveness of contraindication screening, identify new contraindications, and coordinate the distribution of vaccinia immune globulin (VIG) and cidofovir to the civilian population. This notice describes the components of the system, delineates roles and responsibilities, and explains how data from the system will be compiled and communicated. SN - 0149-2195 UR - https://www.unboundmedicine.com/medline/citation/12588007/Smallpox_Vaccine_Adverse_Events_Monitoring_and_Response_System_for_the_first_stage_of_the_smallpox_vaccination_program_ L2 - http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5205a5.htm DB - PRIME DP - Unbound Medicine ER -